Latest News & Updates
Breaking News
1 hour ago
Vaibhavi M.
Other trending news you may like to read
Pfizer’s HYMPAVZI Shows 93% Reduction In Bleeding For Hemophilia Patients With Inhibitors In Phase 3 Study
Pfizer reports Phase 3 BASIS data showing HYMPAVZI significantly reduced bleeding in hemophilia A and B patients with inhibitors.
Vaibhavi M.
Regeneron’s Lynozyfic Delivers Rapid, Deep Responses In Newly Diagnosed Multiple Myeloma; Phase 1/2 LINKER-MM4 Data Highlight Strong Efficacy And Manageable Safety
Regeneron presents Phase 1/2 data showing Lynozyfic delivers rapid, deep responses in newly diagnosed multiple myeloma at the ASH Annual Meeting.
Vaibhavi M.
Sandoz Strengthens Biosimilar Leadership with Acquisition Of Just-Evotec Biologics EU SAS; Secures Toulouse Site And Continuous Manufacturing Tech To Boost Biosimilar Scale
Sandoz completes acquisition of Evotec’s Toulouse biologics site, boosting continuous manufacturing capabilities and strengthening its global biosimilars strategy.
Vaibhavi M.
Praxis Advances Essential Tremor Program After Successful FDA Pre-NDA Meeting And Expects Early 2026 Submission
Praxis secures FDA alignment in its pre-NDA meeting and prepares a 2026 NDA submission for ulixacaltamide, a potential new therapy for essential tremor.
Vaibhavi M.
